Hematological Cancer Research Investment and Education Act of 2001
Last action on Jul 31, 2001Referred to the Subcommittee on Health.
Take Action
Summary
H.R. 2629, the Hematological Cancer Research Investment and Education Act of 2001, aims to increase federal resources dedicated to fighting blood cancers such as leukemia, lymphoma, and multiple myeloma. The bill directs the National Institutes of Health to expand and coordinate research efforts to better understand and treat these diseases. Additionally, it tasks the Centers for Disease Control and Prevention with creating a public information program, in partnership with national patient advocacy groups, to improve education and support services for those affected by blood-related cancers.
AI-generated summary
Lifecycle of the Bill
No events recorded for this stage yet.
